Triskelion Capital

Triskelion Capital is an investment firm based in New York that focuses on identifying business quality and assessing management's capital allocation decisions. The firm specializes in distressed and special situation investments, as well as venture capital opportunities. By concentrating on these areas, Triskelion Capital aims to uncover value in complex financial scenarios and support innovative companies in their growth trajectories.

Caio Blasco

Managing Partner

2 past transactions

Lifesprout

Series A in 2020
LifeSprout is developing the next generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. LifeSprout offers revolutionary products for aesthetic and regenerative medicine. Leveraging recent breakthroughs in materials science, we have created a platform that looks and behaves like the body’s own tissues. The company is turning this into a suite of products for millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease.

Lifesprout

Seed Round in 2018
LifeSprout is developing the next generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. LifeSprout offers revolutionary products for aesthetic and regenerative medicine. Leveraging recent breakthroughs in materials science, we have created a platform that looks and behaves like the body’s own tissues. The company is turning this into a suite of products for millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.